Lorundrostat shows continued promise against uncontrolled hypertension - report from ACC.25

from Medical Digest & Congress Report · host Medical Congress News

Luke Laffin on the phase 2b Advance-HTN study of lorundrostat, whose results were reported in a late-breaking clinical trials presentation at the American College of Cardiology’s 2025 Scientific Session.Video: https://medicaldigest.org/scientific-contents/interview:lorundrostat-shows-continued-promise-against-uncontrolled-hypertension

Episode metadata supplied by the publisher feed · Published Apr 8, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Lorundrostat shows continued promise against uncontrolled hypertension - report from ACC.25

0:00 9:37

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 9 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on April 8, 2025.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!